Earnings Recap — Q2 FY2026
CY Q3 2026 · Reported August 4, 2026 · Beat 4 of last 7 quarters
The Buildout is a website built on agentic AI tools, currently in beta, and could have factual errors.
Bruker's strong semi metrology orders, driven by AI demand for HBM and advanced packaging, reinforce the AI infrastructure buildout thesis, as metrology tools are critical for next-gen chip manufacturing. The company's deep tech portfolio, including energy research and security detection, adds diversification but also longer lead times, creating a delayed revenue impact that could benefit 2027 and beyond.
Bruker returned to organic revenue growth in Q2, with reported revenue of $838.5M up 5.2% YoY, though organic growth of 2.8% was at the low end of expectations due to U.S. tariff refunds and FX. BSI bookings grew 10% organically, driven by strong semi and biopharma demand, while U.S. academic orders remained weak. Non-GAAP operating margin expanded 510 bps to 14.1% and EPS rose 53% to $0.49, aided by cost savings and a $0.06 tariff benefit. The company recorded a $135M goodwill impairment related to automation and spatial biology businesses. Management announced a new operating structure effective July 1, combining BioSpin, Daltonics, and Optics into a Bruker Biosystems Group, and establishing BMID as a separate group.
Management reiterated FY2026 guidance for organic revenue growth of 1% to 2% and non-GAAP EPS of $2.10 to $2.15 (15% to 17% growth), while lowering the FX tailwind assumption to 0.5% from 1.5%. They expect Q3 organic revenue to be roughly flat to slightly up, with ~$20M of semi revenue shifting into Q4, and a strong Q4 with meaningful sequential and YoY growth, potentially around $1B in revenue. Cost savings remain on track for $140M in 2026, with an additional $20M expected in 2027 from the new operating structure. Management signaled continued margin expansion and double-digit EPS growth into 2027.
“We are pleased that Bruker has returned to organic revenue growth in the second quarter and that our focus on cost reductions and profitability improvements resulted in solid margin expansion and non-GAAP EPS growth.”
on Q2 performance
“I would think that the visibility of the sector for the next 6 quarters plus seems excellent.”
on Semiconductor metrology sustainability
“We are very well on track for our stated goal of delivering $140 million of annualized cost savings in 2026.”
on Cost savings program
On the tariff refund treatment, some peers are calling it a pass-through with no net impact. What is embedded in the tariff refund in the second half and for the full year guide?
Gerald explained that some tariff elements were charged to customers, resulting in a contra revenue element. The EPS benefit of roughly 200 bps in Q2 was pulled forward from Q3/Q4, but overall the tariff refunds were already baked into the original guidance model.
Organic was lighter than expected, especially in BSI. Was there anything unusual in the quarter?
Frank cited the combined effect of tariff refunds (60 bps) and lower FX tailwind (50 bps) as the main drags, but the biggest revenue weakness was U.S. aca/gov, which was down more than $15 million YoY due to weak orders in H2 2025.
Was the strength in security detection and energy research orders expected? How sustainable is it into 2027?
Frank said security detection was incrementally better than expected but partly baked in, and looks sustainable given defense concerns. Energy research greatly exceeded expectations with orders up over 100%, and while that growth rate isn't sustainable, the business has multi-year visibility with orders extending into 2027-2029.